Ledger.Open graph →
SEC Form D · filed September 8, 2022

Diasome Pharmaceuticals, Inc

Offering
$19.1M
Sold
$16.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Musheer Ahmed · Atlanta, GADirectorCharles Russell · Spokane, WADirectorW. C. Grubb · Charlotte, NCDirectorThomas B. Mcdonald · Cleveland, OHDirectorRobert Geho · Cleveland, OHExec · Director · PromoterFrank B. Mccaney · Cleveland, OHDirectorMichael Ho · Miami, FLDirectorRohit Pasam · Chicago, ILDirectorMichael Stubben · Las Vegas, NVDirectorTodd R. Williams · Charlotte, NCExec · Director · PromoterMarc B. Penn · Cleveland, OHDirectorMichael Neril · Atlanta, GAExec · Director · PromoterJ.E. R. Taylor, Iii · Charlotte, NCDirectorAhamad Mustaque · Atlanta, GADirectorW. B. Geho · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗